Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models

Published:2017-01-02 Issue:1 Volume:17 Page:39-52
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Fust Kelly¹,Parthan Anju¹,Maschio Michael²,Gu Qing¹,Li Xiaoyan³,Lyman Gary H.⁴,Tzivelekis Spiros³,Villa Guillermo⁵,Weinstein Milton C.⁶

Affiliation:

1. Health Economics & Outcomes Research, Optum, Boston, MA, USA

2. Health Economics & Outcomes Research, Optum, Burlington, ON, Canada

3. Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA

4. Public Health Sciences Division and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

5. Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland

6. Department of Health Policy and Management; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA

Funder

Amgen Inc.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2017.1276829

Reference88 articles.

1. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy

2. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

3. Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin’s lymphoma: cost-effectiveness analyses

4. Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating acute chemotherapy-associated adverse events in patients with cancer;Nature Reviews Clinical Oncology;2022-10-11

2. Pegfilgrastim Prophylaxis is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study;Cancer Research and Treatment;2021-12-30

3. Development and validation of a cycle‐specific risk score for febrile neutropenia during chemotherapy cycles 2–6 in patients with solid cancers: The CSR FENCE score;International Journal of Cancer;2019-03-28

4. Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective;Journal of Managed Care & Specialty Pharmacy;2019-01

5. A Patient Risk Model of Chemotherapy-Induced Febrile Neutropenia: Lessons Learned From the ANC Study Group;Journal of the National Comprehensive Cancer Network;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3